CO150 Indirect Treatment Comparison of Biochemical Control Between Pasireotide Long-Acting Release and Pegvisomant as Second-Line Therapies for Acromegaly, Based on Real-World Evidence
Abstract
Authors
Grzegorz Binowski KOSSI Dédé Sika Malgorzata Bronikowska Anna Packowska Ruth Delgado Beatrice Gueron Fabian Schmidt Sabrina Chiloiro